Mohamed Khaled Diab

13PUBLICATIONS
25CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsGene and molecular therapyMolecular targetsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 16, 2026
Recent Overview on the Molecular Hybrids Integrated With Benzosuberone/Benzo[7]annulene Derivatives as Multi-Target Therapeutics.

|Jun 15, 2026
Triazole-Sulfonamide Hybrids as Carbonic Anhydrase Inhibitors: Emerging Chemistry and Bioactivity Insights From 2020 to 2025.

|May 12, 2026
Dual-Function Lipid-Based Nanovector Strategy for Glioblastoma Immunotherapy: STING Activation and M1 Microglia Polarization.

|Feb 13, 2026
Exploring pyrazoline-thiophene hybrids as CDK2 inhibitors: synthesis, mechanism, biological studies, and computational insights.

Heba M Abosalim, Tarek F El-Moselhy, Nabaweya Sharafeldin

|Dec 09, 2025
Next-Generation Proteolysis-Targeting Chimeras in Precision Oncology: Multifunctional Designs, Emerging Modalities, and Translational Prospects in Targeted Protein Degradation.

Mohamed S Nafie, Mohamed K Diab, Asmaa S A Yassen

|Oct 06, 2025
Click synthesis of some novel benzo[d]thiazole-1,2,3-triazole hybrid compounds with benzamide and/or benzoate tethers as EGFR-dependent signaling inhibitors against breast cancer.

Mosa Alsehli, Mohamed S Nafie, Nader R Albujuq

Pageof 3

Frequent Collaborators

11 joint publications

Mohamed S Nafie

5 joint publications

Sherif Ashraf Fahmy

4 joint publications

Abdelghafar Mohamed Abu-Elsaoud

3 joint publications

Haytham O Tawfik